How Global Capability Centers are Transforming Pharmaceutical Operations
Girish Basavaraju, Country Head – Global Business Operations, Cosette Pharmaceuticals, Inc.
Girish Basavaraju leads the global operations that connect Cosette's development, manufacturing, and commercial functions across geographies. He brings over two decades of pharma leadership spanning process R&D, manufacturing, quality, sustainability, and business operations. Earlier, at Syngene International, he rose through engineering and research roles to head MSAT, Sustainability & Special Projects, and helped build the oligonucleotides business unit from the ground up. A Six Sigma Black Belt with a PhD and an MBA from IIM Kozhikode, he is a frequent speaker on operational excellence, digital transformation, and the evolving role of Global Capability Centers in pharma.
Cosette Pharmaceuticals is a US-based, fully integrated pharmaceutical company with in-house product development, manufacturing, and commercial distribution capabilities, along with a growing CDMO business. Its portfolio spans complex dosage forms — including creams, ointments, liquids, solutions, and suppositories — serving customers across the United States and beyond, supported by global operations that increasingly rely on capability centers to scale efficiently.
Setting up or scaling Global Capability Centers.
Moving centers up the value chain toward innovation and analytics.
Embedding AI, automation, and data across operations.
Connecting global sites with capability centers.
Building compliant, audit-ready global processes.
Driving visibility across the production network.
Attracting, building, and retaining specialized GCC talent.
Designing operating models and governance.
Planning global operations and scale-up early.
Join industry leaders for this exclusive deep‑dive into building the intelligent pharma enterprise.
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.